US Patent 8188224 Variant forms of urate oxidase and use thereof
Patent 8188224 was granted and assigned to Savient Pharmaceuticals, Inc. on May, 2012 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8188224 Variant forms of urate oxidase and use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
